Natural and engineered antibodies against HIV by Berger, Edward A
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Oral presentation
Natural and engineered antibodies against HIV
Edward A Berger*
Address: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 
20892, USA
* Corresponding author    
The humoral arm of the immune system exerts continual
selective pressure on HIV replication in the infected per-
son. We have described a conserved epitope within the
gp120 V3 loop that is masked in the native Env trimer on
CCR5-restricted (R5) HIV-1 virions, but fully exposed on
CXCR4-using (X4, R5X4) virions. The ability of a mono-
clonal antibody against this epitope to selectively neutral-
ize CXCR4-using but not CCR5-restricted primary isolates
raises the question of whether in vivo neutralizing anti-
body selection pressure in the acutely infected person
plays a major role in the selective transmission of R5
viruses.
We are exploiting antibodies to engineer novel bifunc-
tional proteins against HIV infection. One agent, desig-
nated sCD4-17b, is based on the sequential receptor
binding mechanism of gp120: first to CD4, then to core-
ceptor. The sCD4 moiety of the chimeric protein binds
and induces the conformational change required to
expose/create the highly conserved "bridging sheet"
involved in coreceptor binding and containing the 17b
epitope. The potent neutralizing activity of sCD4-17b
against diverse HIV-1 primary isolates suggests its poten-
tial utility as a topical microbicide to protect against HIV-
1 sexual transmission. [1,2].
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